x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DIA-0230800
| Product Information | |
|---|---|
| CAS No. | 1014691-61-2 |
| Chemical Name | 3-[[[2-Methoxy-4-(phenylamino)phenyl]amino]sulfonyl]-2-thiophenecarboxylic acid methyl ester |
| Formula | C19H18N2O5S2 |
| Molecular Weight | 418.48 |
| PubChem CID | 46233311 |
| SMILES | O=S(=O)(Nc2ccc(Nc1ccccc1)cc2OC)c3ccsc3C(=O)OC |
| Target | Zinc Finger |
| Product Description | GSK0660 is a potent PPARβ/δ antagonist with a pIC50 of 6.8 (binding assay IC50 = 155 nM; antagonist assay IC50 = 300 nM) and is nearly inactive on PPARα and PPARγ with IC50s above approximately 10 μM. |
| Format & Storage | |
|---|---|
| Format | Solid |
| Purity | > 99% |
| Source | Synthetic |
| Shipping | Shipped on dry ice. |
| Storage | Store at +4 °C. The product can be stored for up to 12 months. |
| Solubility Overview | Soluble in DMSO to 100 mM |
Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
